Ahiflower® oil: Optimal vegan omega-3-6-9 profile

Our vegan omega-3-6-9 oil from Ahiflower® (Buglossoides arvensis) is ideal for high-performance plant-based nutrition. The oil’s neutral taste and excellent oxidative stability position it as an optimal choice for premium omega-3 supplements, functional beverages, and liquid formulations. When combined with algae-based docosahexaenoic acid (DHA), Ahiflower® creates a nutritionally complete, fish-free omega-3 solution—perfect for sustainability-driven brands.

Re-defining plant-based omega-3 nutrition

Ahiflower® is a next-generation, soil-grown source of omega-3-6-9—100% vegan and responsibly cultivated, with a uniquely complete fatty acid profile that includes:

  • Alpha-linolenic acid (ALA)—comparable to linseed, but with added benefits
  • Stearidonic acid (SDA)—rare in nature, and at levels unmatched in any other dietary oil
  • Gamma-linolenic acid (GLA)—as found in evening primrose, but uniquely combined here with omega-3s
  • Exceptional eicosapentaenoic acid (EPA) conversion efficiency—outperforming flax and chia among all plant-based sources

This rare profile sets a new benchmark as the first truly effective land-based alternative to fish and algal oils.

A hidden lipid champion

  • No. 1 in SDA: 20% SDA content—unique in the plant kingdom
  • No. 1 in omega-3: 65% omega-3 content—higher than in any other plant, algal, or fish oil
  • No. 1 in anti-inflammatory fats: 71% combined ALA, SDA, and GLA—unmatched in nature

A breakthrough in EPA availability among vegan omega-3-6-9 oils

Modern diets are often deficient in omega-3 fatty acids, and most plant-based oils—especially those containing only ALA—fall short when it comes to providing meaningful EPA. Here’s the breakthrough: Ahiflower® oil contains both ALA and SDA, a direct metabolic precursor to EPA.

While only about 5–6% of ALA from typical plant oils like flaxseed converts to EPA, the body converts SDA to EPA at significantly higher rates—up to 30–40%. Ahiflower® is the richest known natural source of SDA, making it uniquely effective among vegan omega-3-6-9 oils.

Unlike conventional ALA-only sources, Ahiflower® allows the body to access EPA through a more direct and efficient metabolic pathway—offering a plant-based shortcut to long-chain omega-3 benefits, without fish or fermentation.

Efficient conversion into EPA

Sourcing and manufacturing: From soil to oil

The oil is produced in partnership with Natures Crops, a leader in regenerative contract farming and the original developer of Ahiflower®. With over 20 years of experience, Natures Crops manages the entire value chain—from non-GMO seed to final product.

Grown by dedicated family farmers in the UK, this plant oil is fully traceable and consistently high in quality. It is gently extracted without solvents, preserving both nutritional integrity and stability. With no bitterness and a mild taste, the oil meets strict standards for purity, safety, and clean-label compliance.

From seed selection to final delivery, we offer a tightly controlled, sustainable supply chain—ready to support premium plant-based formulations.

Key manufacturing facts:

  • 100% non-GMO and sustainably farmed
  • Rich in SDA and GLA—rare among plant oils
  • Unique vegan omega-3-6-9 fatty acid profile
  • Solvent-free extraction process
  • Backed by human clinical trials
  • Suitable for organic-compatible and clean-label formulations
  • Available in both oil and powder formats

Ahiflower®: Trusted by Nature. Proven by Science.

Scientific studies confirm the efficacy of this plant-based omega-3-6-9 oil. Its composition and metabolic effects have been validated in both preclinical and human trials, showing strong results in cardiovascular, cognitive, metabolic, and gut health.

 Key findings:

  • Most efficient plant-based source for human EPA synthesis
  • Potential conversion of Ahiflower® ALA and SDA to DHA in brain and liver tissues
  • Has been shown to have anti-inflammatory activity comparable to fish oil
  • Supports gut microbiome health and functions as a prebiotic

Ahiflower® oil: Published research

  • Baker E et al (2025), Recognizing the health benefits of plant-sourced omega-3 stearidonic acid: exploring its complementary role to preformed EPA/DHA, Lipids 0:1-8 doi: 10.1002/lipd.12452. Link
  • Baker EJ et al, Omega-3 LC-PUFA consumption is now recommended for women of childbearing age and during pregnancy to protect against preterm and early preterm birth: implementing this recommendation in a sustainable manner. Front Nutr,2024. 11:1502866. Link
  • Calder PC, Novel lipid emulsion supports positive outcomes in piglets receiving total parenteral nutrition. J Nutr, 2024. Dec 28:S0022-3166(24)01241-0. Link (summary)
  • Fisk HL, Shaikh SR, Emerging mechanisms of organ crosstalk: the role of oxylipins. Nutrition Bulletin. 2024;00:1–18. Link
  • Laevski et al (2024) Dietary omega‑3 fatty acids modulate the production of platelet‑derived microvesicles in an in vivo inflammatory arthritis model. Eur J Nutr 63, 2221–2234 (2024). Link (summary)
  • Lucchinetti et al (2024) The novel lipid emulsion Vegaven is well tolerated and elicits distinct giological actions compared with a mixed-oil lipid emulsion containing fish oil: a parenteral nutrition trial in piglets. J Nutr 2024. Link
  • Metherel A (2024) Blood and tissue docosahexaenoic acid (DHA, 22:6n-3) turnover rates from Ahiflower® oil are not different than from DHA ethyl ester oil in a diet switch mouse model. BBA – Molecular and Cell Biology of Lipids 1869, 159422. Link (summary)
  • Roussel et al (2024) Human gut microbiota and their production of endocannabinoid-like mediators are directly affected by a dietary oil. J Gut Microbes16:1, 2335879. Link
  • Seidel U et al (2024) Stearidonic acid improves eicosapentaenoic acid status: studies in humans and cultured hepatocytes. Front. Nutr. 11:1359958. Link
  • Baker EJ (2023) Alternative sources of bioactive omega-3 fatty acids: what are the options? Curr Opin Clin Nutr Metab Care 27(2):p 106-115, March 2024. Link
  • El-Zenary A (2023), Comparison of Ahiflower oil containing stearidonic acid to a high-alpha-linolenic acid flaxseed oil at two dietary levels on omega-3 enrichment of egg yolk and tissues in laying hens. J Lipids 2023; 1-17. Link
  • Lucchinetti E (2022) Novel lipid emulsion for total parenteral nutrition based on 18-carbon n–3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions, Am J Clin Nutr, 0:1–15. Link
  • Jerina ML (2021) Palatability of Ahiflower oil versus flaxseed and fish oil. J Equine Vet Sci 100 (2021) 103532 Link (summary)
  • Venema K et al. (2020) Survival of a probiotic-containing product using capsule-within-capsule technology in an in vitro model of the stomach and small intestine (TIM-1). Beneficial Microbes, 2020; 11(4): 403-409. Link (summary)
  • Fickler A (2018) Dietary Buglossoides arvensis oil as a potential candidate to substitute fish oil in rainbow trout diets, Lipids 53(8). Link (summary)
  • Lefort (2017) Dietary Buglossoides arvensis oil increases circulating n-3 polyunsaturated fatty acids in a dose-dependent manner and enhances lipopolysaccharide-stimulated whole blood interleukin-10—a randomized placebo-controlled trial. Nutrients 9:261; 1-17. Link
  • Lefort (2016) Consumption of Buglossoides arvensis seed oil is safe and increases tissue long-chain n-3 fatty acid content more than flax seed oil. J Nutr Sci 5:e2, 1-12. Link
  • Cumberford G & Hebard A (2015) Ahiflower oil: A novel non-GM plant-based omega-3+6 source. J Lipid Tech 27:9;207-210. DOI 10.1002/lite.201500044 Link
  • Surette (2013) Dietary omega-3 PUFA and health: stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils, Mol Nutr Food Res 00, 1-12. Link (summary)

How can we help you?

Hendrik Rösel

Hendrik Rösel
Lead IMF Sales

Edda Marwede

Edda Marwede
Product Manager 

Read more

Omega-3 Fish Oil & Powder

Vegan Omega-3 Algal Oil & Powder

Omega-6 ARA Oil & Powder

Privacy Policy   |   Legal Notice   |   Contact

We look forward to your call

Chris Kommerowski
Sales Director

  • +49 40 33 85 33-40
  • +49 172 54 54 192

Marco Heins 
Product Manager

  • +49 40 33 85 33-36
  • +49 172 54 54 197

Kruna Ramljak
Product Manager

  • +49 40 33 85 33-32
  • +49 174 33 56 422

Christina Wegener 
Logistics & Sales Manager

  • +49 40 33 85 33-55

Felix Wohlers
Logistics Manager

  • +49 40 33 85 33-44

Dirk De Deyn 
Sales Director

  • +32 473 215 034

Charlotte Grüttner
Logistics Manager

  • +49 40 33 85 33-41

Tim Rathje 
Product Manager

  • +49 40 33 85 33-34

Hendrik Rösel
Sales Manager

  • +49 40 33 85 33-47

Edda Marwede 
Sales Manager

  • +49 40 33 85 33-43

Ina von Oertzen
Business Development Director

  • +49 152 233 44 565

Loyana Camelo 
Assistant Sales & Logistics

  • +49 40 33 85 33-52

How can we help you?

Hendrik Rösel Lead IMF Sales

  • +49 40 33 85 33-47

Edda Marwede Product Manager

  • +49 40 33 85 33-43

Dr. Markus Langenfeld BD & Sales Manager

  • +49 40 33 85 33-48

Tim Rathje Product Manager

  • +49 40 33 85 33-34

Loyana Camelo Logistics Manager

  • +49 40 33 85 33-52

How can we help you?


See you at

Nürnberg | 11-14 Feburary 2025

Oliver Kromer
Managing Director

Edda Marwede
Product Manager

Tim Rathje
Product Manager